Stay updated on Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a new published iteration of the page.
    Difference
    0.1%
    Check dated 2026-06-05T11:21:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer branding and sponsor-related navigation text on the study page has been removed, changing how institutional affiliation and related links are presented at the bottom of the page.
    Difference
    0.2%
    Check dated 2026-05-29T07:38:04.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from v3.5.3 to v3.5.4. This indicates an underlying platform or template update without altering the study details.
    Difference
    0.1%
    Check dated 2026-05-14T23:17:14.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.2 to v3.5.3, indicating a minor update to the page template. This update does not alter the study details or data presented on the page.
    Difference
    0.1%
    Check dated 2026-04-30T16:41:21.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Changelog updated with Revision: v3.5.2 added and Revision: v3.5.0 removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:35:07.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:16:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.